Canada Remote Patient Monitoring (RPM) Market (2026-2031)
The Canada Remote Patient Monitoring (RPM) Market was valued at $528.3 Million in 2026 and projected to reach to $724.7 Million by 2031, representing a compound annual growth rate of 6.5%. Canada's Remote Patient Monitoring market is positioned for steady growth as healthcare providers seek cost-effective solutions to manage chronic diseases and reduce hospital burden.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada Remote Patient Monitoring (RPM) Market Trends and Insights
- This moderate but steady expansion reflects Canada's increasing adoption of digital health technologies and the country's commitment to modernizing its healthcare infrastructure.
- Canada's RPM market is being driven by aging demographics, rising chronic disease prevalence, and government initiatives supporting telehealth integration across provincial health systems. The Canadian RPM landscape is characterized by strong regulatory support and integration with existing public healthcare frameworks.
- Canada's healthcare providers are increasingly deploying RPM solutions to manage patient populations remotely, reduce hospital readmissions, and improve care coordination.
- Between 2026 and 2031, Canada is expected to see accelerated investment in RPM platforms, particularly in chronic disease management and post-acute care settings. Canada's RPM market growth is supported by favorable reimbursement policies, provincial health authority partnerships, and the country's advanced digital infrastructure.
- As Canada continues to address healthcare capacity challenges, RPM adoption is positioned as a key enabler of patient-centered care delivery across the nation..
Key Market Statistics
- CAGR (2026-2031) 6.5% CAGR
- Market Size, 2026 ~USD 528.3 Million
- Forecast, 2031 ~USD 724.7 Million
- Country Canada
Canada Remote Patient Monitoring (RPM) Market Overview
Market Size & Growth :
Canada's RPM market is valued at $528.3 million in 2026 and projected to reach $724.7 million by 2031, with a steady CAGR of 6.5%, reflecting consistent healthcare digitalization efforts.
Provincial Healthcare Integration :
Canada's publicly funded healthcare system is increasingly integrating RPM solutions to reduce hospital readmissions and manage chronic diseases across provinces, particularly in aging populations.
Digital Health Infrastructure :
Government initiatives and provincial health authorities are investing in telehealth and remote monitoring infrastructure, supported by regulatory frameworks that encourage digital health adoption.
Chronic Disease Management Focus :
Rising prevalence of diabetes, hypertension, and cardiovascular diseases in Canada is driving demand for continuous patient monitoring solutions to improve outcomes and reduce healthcare costs.
Canada Remote Patient Monitoring (RPM) Market Dynamics
- The country's universal healthcare system is increasingly adopting RPM technologies to enhance patient outcomes while controlling expenditures.
- Provincial health authorities are prioritizing digital health investments, creating favorable conditions for RPM solution deployment across primary care, specialty clinics, and home-based care settings. The market will be supported by aging demographics, rising chronic disease prevalence, and government funding for healthcare modernization.
- However, growth remains moderate compared to global markets due to slower technology adoption rates and regulatory complexities across provinces.
- Strategic partnerships between technology vendors and provincial health systems will be critical to accelerating RPM penetration and achieving the projected $724.7 million market size by 2031..
Related Ecosystem
Cardiovascular Devices
Diagnostic Imaging
Healthcare It
Key Takeaways
- Canada's RPM market is valued at $528.3 million in 2026 and will reach $724.7 million by 2031, growing at 6.5% CAGR.
- Canada's aging population and rising chronic disease burden are primary drivers of RPM adoption across provincial health systems.
- Canada's regulatory environment and public healthcare integration create favorable conditions for RPM vendor partnerships and reimbursement expansion.
- Canada is expected to see increased investment in RPM platforms for chronic disease management and post-acute care between 2026 and 2031.
Remote Patient Monitoring (RPM) Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SYNCHRONOUS (Transmission Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 12.8% from 2026 to 2031 |
| Largest Segment | HEALTHCARE PROVIDERS (End User) |
| Market Size Base Year (Billions) | ~USD 36.32 (2026) |
| Revenue Forecast (Billions) | ~USD 66.33 (2031) |
| Segments Covered | Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type |
Canada Remote Patient Monitoring (RPM) Market Report Segmentation
8 segment dimensions are covered across the global market.
By Component
- Devices
- Services
- Software
By Function
- Blood Glucose Monitoring
- Cardiac Monitoring
- Fetal & Neonatal Monitoring
- Multiparameter Monitoring
- Neurological Monitoring
- Other Monitoring Devices
- Pulse Oximeters
- Respiratory Monitoring
- Thermometers
- Weight Monitoring
By Type
- Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
- Handheld & Portable
- Handheld & Portable Devices
- Home Healthcare
- Hospitals
- Implantable
- Implantable Devices
- Long-Term Care & Assisted Living Facilities
- Other Healthcare Providers
- Others (Stationary Devices And Others)
- Others (Stationary Devices, And Others)
- Wearable
- Wearable Devices
By Deployment Model
- Cloud-Based Model
- On-Premise Model
By Transmission Type
- Asynchronous
- Synchronous
By Indication
- Cardiology
- Diabetes
- Mental Health
- Neurology
- Oncology
- Other Indications
- Respiratory Disorders
- Sleep Disorders
- Wellness Improvement
By End User
- Healthcare Payers
- Healthcare Providers
- Medtech Companies
- Other End Users
- Patients
- Pharmaceutical & Biotechnology Companies
By Deployment Type
- Cloud-Based
- On-Premises
CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PAYERS | 155 | 170.8 | 186.8 | 203 | 219.3 | 235.5 | 251.3 | 266.7 | 7.4 |
| HEALTHCARE PROVIDERS | 292.7 | 321.5 | 350.5 | 379.7 | 409 | 437.9 | 466 | 493 | 7.1 |
| MEDTECH COMPANIES | 25.1 | 27.4 | 29.7 | 31.9 | 34.2 | 36.3 | 38.4 | 40.3 | 6.3 |
| OTHER END USERS | 17.8 | 19.6 | 21.3 | 23.1 | 24.8 | 26.5 | 28.2 | 29.7 | 6.9 |
| PATIENTS | 91.2 | 100.7 | 110.5 | 120.4 | 130.5 | 140.6 | 150.5 | 160.1 | 7.7 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 50.4 | 55.1 | 59.8 | 64.6 | 69.3 | 73.9 | 78.3 | 82.5 | 6.6 |
| TOTAL | 632.2 | 695.2 | 758.7 | 822.7 | 887 | 950.7 | 1012.6 | 1072.4 | 7.2 |
Target Audience
- Healthcare Technology Vendors : RPM solution providers need Canada-specific market data to develop localized products, navigate provincial regulations, and identify partnership opportunities with health authorities and hospital networks.
- Provincial Health Authorities : Decision-makers in provincial health systems require market intelligence to evaluate RPM vendors, benchmark adoption rates, and justify digital health investments to government stakeholders.
- Healthcare Investors & PE Firms : Investment professionals targeting Canada's healthcare sector need detailed market sizing, growth forecasts, and competitive analysis to identify acquisition targets and fund allocation opportunities.
- Medical Device & Pharma Companies : Organizations developing connected devices and medications need Canadian market insights to integrate RPM capabilities, understand reimbursement pathways, and support clinical evidence generation.
- Healthcare Consultants & Advisors : Strategy consultants advising healthcare organizations and government agencies require Canada-specific RPM data to develop digital transformation roadmaps and policy recommendations.
Key Companies in the Canada Remote Patient Monitoring (RPM) Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring), |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| ORACLE | United States | Public Company | Cloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain), |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| BAXTER | United States | Public Company | Medical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services), |
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.
MEDTRONIC
Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.
GE HEALTHCARE
GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.
ABBOTT
Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.
ORACLE
Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.
BOSTON SCIENTIFIC CORPORATION
Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.
NIHON KOHDEN CORPORATION
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.
BAXTER
Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.
Reasons to Buy this Report
- Provincial Market Segmentation : Understand market dynamics across Canada's 10 provinces and 3 territories, with detailed insights into regional healthcare spending patterns and RPM adoption rates specific to each jurisdiction.
- Competitive Landscape Analysis : Identify key RPM vendors operating in Canada, their market share, partnerships with provincial health authorities, and competitive positioning strategies tailored to the Canadian healthcare ecosystem.
- Regulatory & Reimbursement Framework : Gain clarity on Canada's unique regulatory environment, provincial reimbursement models, Health Canada approvals, and coverage policies that directly impact RPM market opportunities and vendor strategies.
- Investment & Growth Opportunities : Discover high-potential segments within Canada's RPM market, including chronic disease management, post-acute care, and home health monitoring, with specific growth projections through 2031.
- Strategic Partnership Insights : Access data on successful partnerships between technology vendors, healthcare providers, and government agencies in Canada, enabling informed go-to-market and collaboration strategies.
Frequently asked questions
What is the current size of Canada's RPM market?
Canada's Remote Patient Monitoring market is valued at $528.3 million in 2026 and is projected to grow to $724.7 million by 2031.
What is the growth rate of Canada's RPM market?
Canada's RPM market is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2031.
What are the main drivers of RPM adoption in Canada?
Canada's RPM market is driven by aging demographics, rising chronic disease prevalence, government telehealth initiatives, and provincial health authority partnerships supporting digital health integration.
How is Canada's RPM market different from other North American markets?
Canada's RPM market is characterized by integration with public healthcare systems, provincial regulatory frameworks, and government-supported reimbursement policies that differ from the United States market structure.
Which healthcare segments are driving RPM growth in Canada?
Chronic disease management, post-acute care, and hospital readmission reduction are the primary healthcare segments driving RPM adoption and investment in Canada.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the remote patient monitoring market.
Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.
Market Definition
The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.
Key Stakeholders
- RPM Equipment and devices Manufacturers
- Suppliers and Distributors of RPM Equipment
- RPM software provider
- Healthcare IT Service Providers
- Healthcare Insurance Companies/Payers
- Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
- Venture Capitalists
- Government Bodies/Regulatory Bodies
- Corporate Entities
- Accountable Care Organizations
- RPM Resource Centers
- Research and Consulting Firms
- Medical Research Institutes
- Clinical Departments
Report Objectives
- To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
- To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries
Get the Full Remote Patient Monitoring (RPM) Market Report
Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.
- Rest Of Europe Remote Patient Monitoring (RPM) Market
- Rest Of Asia Pacific Remote Patient Monitoring (RPM) Market
- US Remote Patient Monitoring (RPM) Market
- Germany Remote Patient Monitoring (RPM) Market
- UK Remote Patient Monitoring (RPM) Market
- France Remote Patient Monitoring (RPM) Market
- Italy Remote Patient Monitoring (RPM) Market
- Spain Remote Patient Monitoring (RPM) Market
- China Remote Patient Monitoring (RPM) Market
- Japan Remote Patient Monitoring (RPM) Market
- India Remote Patient Monitoring (RPM) Market
- Australia Remote Patient Monitoring (RPM) Market
- South Korea Remote Patient Monitoring (RPM) Market
- Brazil Remote Patient Monitoring (RPM) Market
- Mexico Remote Patient Monitoring (RPM) Market
- Saudi Arabia Remote Patient Monitoring (RPM) Market
- UAE Remote Patient Monitoring (RPM) Market
- South Africa Remote Patient Monitoring (RPM) Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report